Am J Gastroenterol
- CHAUDHARY U, Anouti A, Rule JA, Lee WM, et al
Evolution of Hepatitis A-Related Acute Liver Failure in North America Over 22
Years.
Am J Gastroenterol. 2025 Aug 22. doi: 10.14309/ajg.0000000000003743.
Arch Virol
- ZADEH MEHRIZI T, Eshrati B, Ebrahimi Shahmabadi H
Evaluation of recent pre-booster studies on hepatitis B vaccine effectiveness
across WHO regions with HBV prevalence above 1% in the general population up to
60 years of age: a systematic review.
Arch Virol. 2025;170:193.
BMC Cancer
- WANG L, Yang F, Dong Q, Tung TH, et al
Anti-PD-1 therapy achieves favorable outcome in gastric cancer combined with
chronic hepatitis B.
BMC Cancer. 2025;25:1354.
BMC Gastroenterol
- ALI AM, Abdelrahim ME, AbdelMagid AM
Mycophenolate mofetil versus azathioprine as a first-line treatment for
autoimmune hepatitis: a comparative systematic review and meta-analysis.
BMC Gastroenterol. 2025;25:613.
Eur J Gastroenterol Hepatol
- HU Y, Liu M, Li S, Ji Y, et al
Co-occurrence of autoimmune liver disease and gallstones: a clinically overlooked
phenomenon.
Eur J Gastroenterol Hepatol. 2025 Mar 26. doi: 10.1097/MEG.0000000000002978.
Gastroenterology
- KUSHNER T, Cohen SM, Ahn J, Wong RJ, et al
AGA Clinical Practice Update on Management of Hepatitis Delta: Commentary.
Gastroenterology. 2025 Aug 20:S0016-5085(25)05842.
Gut
- FAN T, Wang J, Zhu C, Wu C, et al
Prevalence of serum HBsAg <100 IU/mL in inactive chronic hepatitis B.
Gut. 2025 Aug 24:gutjnl-2025-336520. doi: 10.1136/gutjnl-2025-336520.
- SU CW, Liang YJ, Wu JC
Unravelling the heterogeneous HCC risk in indeterminate chronic hepatitis B.
Gut. 2025 Aug 18:gutjnl-2025-335915. doi: 10.1136/gutjnl-2025-335915.
Hepatology
- URBANEK-QUAING M, Chou YH, Gupta MK, Steppich K, et al
Enhancing HBV-specific T cell responses through a combination of epigenetic
modulation and immune checkpoint inhibition.
Hepatology. 2025;82:739-754.
J Clin Microbiol
- SUZUKI T, Ohue C, Arai O, Inose Y, et al
Evaluation of fully automated chemiluminescent enzyme immunoassays for hepatitis
B core-related antigen components, phosphorylated and non-phosphorylated
hepatitis B core antigens: clinical significance and dynamics during hepatitis B
e antigen seroco
J Clin Microbiol. 2025 Aug 19:e0038525. doi: 10.1128/jcm.00385.
J Hepatol
- HOFMANN M, Rehermann B
T Cells in a Drop: Rapid T Cell Monitoring in Chronic Hepatitis B.
J Hepatol. 2025 Aug 22:S0168-8278(25)02443-2. doi: 10.1016/j.jhep.2025.
J Infect Dis
- WEGERMANN K, Lucas JE, Dubois L, Mangus R, et al
Plasma lipid metabolites differentiate metabolic from viral chronic liver
disease.
J Infect Dis. 2025 May 23:jiaf270. doi: 10.1093.
- YU H, Li B, Guo H, Li L, et al
SLC22A1 Resists Hepatitis B Virus by Activating the JAK/STAT Pathway and Predicts
the Effect of Pegylated Interferon alpha-Based Therapy on Chronic Hepatitis B.
J Infect Dis. 2025;232:474-484.
- MADUT DB, Rubach MP, Allan KJ, Thomas KM, et al
Epidemiologic and Genomic Characterization of an Outbreak of Rift Valley Fever
Among Humans and Dairy Cattle in Northern Tanzania.
J Infect Dis. 2025;232:298-307.
J Med Virol
- BERTONI C, Diotallevi S, Lolatto R, Piromalli G, et al
Hepatitis B Viral Rebound in People With HIV Under HBV-Active Antiretroviral
Therapy.
J Med Virol. 2025;97:e70573.
J Viral Hepat
- GREEN F, Simmons R, Leeman D, Desai M, et al
Global Systematic Review of the Measurement of Stigma Associated With People
Living With Hepatitis B or Hepatitis C Viruses.
J Viral Hepat. 2025;32:e70064.
- REMY AJ, Bellon S, Smadhi R, Bottlaender J, et al
HCV Screening Before Endoscopy in Hepatogastroenterology Outpatient Clinic: The
Depist C Endo Study.
J Viral Hepat. 2025;32:e70063.
PLoS One
- JIN Y, Lu R, Wang M, Xu Z, et al
Analysis of blood screening strategies and their efficacy among voluntary blood
donors in a region of East China.
PLoS One. 2025;20:e0331027.
Transplantation
- PRZYBYSZEWSKI EM, Kotton CN
Detection Is Protection: Adherence to Mandated HCV Testing After Liver
Transplant.
Transplantation. 2025 Aug 22. doi: 10.1097/TP.0000000000005516.
Virology
- ZENG F, Liu Q, Wang X, Zhong P, et al
Immunoinformatics design and experimental expression of a multi-epitope vaccine
simultaneously targeting AAV2 and HAdV-F41 against acute hepatitis of unknown
etiology.
Virology. 2025;611:110653.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016